We were pleased to announce that CHOSA Oncology presented at the Økonomisk Ugebrev Investor Conference on April 23, 2025.

Our Chief Operating Officer, Claus Frisenberg, provided an update on the company’s strategic direction, recent developments, and progress in advancing our oncology pipeline. It was wonderful to see so many familiar faces and connect with investors, industry leaders, and stakeholders during this important event. This conference offered a key opportunity for innovative companies to engage with investors and provided valuable insights into the latest trends within the life sciences sector.

The event took place at Symbion, Fruebjergvej 3, 2100 København Ø, Lokale K1, from 13:30 to 17:30 CET. We were grateful for the warm reception and the chance to be part of such a dynamic gathering.

Økonomisk Ugebrev, a well-established private media house, has been delivering insightful journalism and analysis for more than 25 years. Their specialized newsletters, including ØU Formue and ØU Life Science, directly target investors, and their investor conferences provide a platform for companies to present their strategies and innovations, helping investors make informed decisions about their stock investments.